Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 19, 2021 6:22pm
193 Views
Post# 34024785

Today’s House Position - 1% of O/shares in two days

Today’s House Position - 1% of O/shares in two days
House Positions for C:ARCH from 20211019 to 20211019
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 68,400 188,846 2.761 4,000 11,400 2.85 64,400 -177,446
83 Mackie 25,000 70,666 2.827 500 1,400 2.80 24,500 -69,266
53 Morgan Stanley 15,503 42,801 2.761 0   15,503 -42,801
89 Raymond James 7,012 19,881 2.835 3,132 8,588 2.742 3,880 -11,293
2 RBC 6,200 17,496 2.822 2,800 7,588 2.71 3,400 -9,908
124 Questrade 7,007 19,100 2.726 3,797 10,161 2.676 3,210 -8,939
85 Scotia 9,064 25,707 2.836 6,904 18,205 2.637 2,160 -7,502
88 Credential 190 545 2.868 0   190 -545
68 Leede 1,101 2,858 2.596 945 2,630 2.783 156 -228
84 Ind Trading 50 142 2.84 16 45 2.813 34 -97
33 Canaccord 1,500 4,170 2.78 1,500 4,082 2.721 0 -88
80 National Bank 13,626 37,736 2.769 13,645 37,928 2.78 -19 192
14 ITG 77 205 2.662 233 652 2.798 -156 447
13 Instinet 2,200 5,912 2.687 2,500 7,087 2.835 -300 1,175
9 BMO Nesbitt 3,500 9,760 2.789 6,350 17,929 2.823 -2,850 8,169
62 Haywood 0   6,000 16,570 2.762 -6,000 16,570
79 CIBC 13,700 38,890 2.839 27,959 76,224 2.726 -14,259 37,334
7 TD Sec 26,780 72,490 2.707 57,729 163,534 2.833 -30,949 91,044
1 Anonymous 50,900 141,738 2.785 113,800 314,921 2.767 -62,900 173,183
TOTAL 251,810 698,943 2.776 251,810 698,944 2.776 0 1

<< Previous
Bullboard Posts
Next >>